Subcommittee adopts amendments tightening medical cannabis rules and reporting bill to the board
Get AI-powered insights, summaries, and transcripts
Subscribe
Summary
HB391, as amended, updates Virginia's medical cannabis program — definitions, labeling, testing, licensing of processors and dispensaries, and safety standards — and was recommended for report with amendments by the subcommittee and approved on the board vote.
A House subcommittee reported House Bill 391, with amendments, updating Virginia's medical cannabis program to strengthen product labeling, testing and delivery requirements and to require licensing for pharmaceutical processors and cannabis dispensing facilities.
Chair McClure moved the amendments. As amended the bill updates key statutory definitions, sets safety, security and operational standards for licensed processors and dispensaries, and requires independent laboratory testing before products are dispensed, according to the subcommittee report. The subcommittee recommended reporting with amendments by a unanimous vote (7–0), and the board approved the report 21–0.
The amendments aim to tighten regulatory oversight of the existing medical program, placing explicit requirements on labeling and testing and clarifying licensing categories. The transcript records the subcommittee's unanimous support for the amendments; no fiscal action or referral to Appropriations was recorded in this segment.
The measure will proceed in the process with the committee's report and any next steps determined by chamber rules and subsequent committee consideration.